The pharmaceutical industry has bounced back in 2024. After barely growing by 0.5% in 2023, the sector has made a solid ...

Amid EU's carbon tax and slowing consumption in Europe, a silver lining is the border disengagement with China this year ...

U.S. Magistrate Judge Katharine H. Parker, presiding over the pre-trial hearings of Luigi Mangioneaccused of murdering ...

The Schwab US Dividend Equity ETF (NYSE:SCHD) has given back more than half of its one-year gains in the last month, with the ...

Colorado legislators may be asked to adopt a law about hospital drug discounts. Advocates and opponents accuse each other of ...

Pharma department has reprimanded AbbVie Healthcare for sending 30 doctors to Paris and Monaco, spending over Rs 1.9 crore, ...

China's State Administration for Market Regulation (SAMR) has released the draft Compliance Guidelines for Healthcare Companies to Prevent ...

From Pfizer to AstraZeneca and the Omnicom-IPG Merger, the industry has seen a number of executive moves during this year.

To navigate this increasingly complex environment in 2025, pharma manufacturers must fundamentally rethink their models and ...

Mark Cuban Cost Plus Drug Co. has seen exponential growth since its launch, supplying thousands of healthcare facilities with discounted generics in shortage.

The funds will support its mission to provide data-driven insights for Africa's pharmaceutical sector ...

Enanta Pharmaceuticals (ENTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the ...